Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

The Federal Trade Commission filed a lawsuit to prevent Edward LifeSciences from acquiring JenaValve Technology, arguing the deal would stifle innovation in treatments for aortic regurgitation, a ...

A year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing ...

In its own statement, Edwards said it disagrees with the FTC’s belief that the acquisition will limit access to a new therapy ...

The FTC asserts that Edwards acquisition of JenaValve, given it now owns rival TAVR-AR firm JC Medical, will eliminate ...

The U.S. Federal Trade Commission (FTC) reported Aug. 6 that it will try to block Edwards Lifesciences Corp.’s proposed ...

The U.S. Federal Trade Commission has sued to block Edwards Lifesciences Corp's acquisition of JenaValve Technology Inc, ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

The Federal Trade Commission has moved to block Edwards Lifesciences' proposed acquisition of medical-device company JenaValve Technology. The FTC said in a complaint filed Wednesday the acquisition ...

Edwards Lifesciences announced that the U.S. Federal Trade Commission (FTC) seeks to block its planned $1.2 billion ...

FTC sues to block Edwards Lifesciences' $1.2B JenaValve deal. Edwards disputes, revises 2025 EPS guidance, and pursues ...

The US Federal Trade Commission filed suit Wednesday to block Edwards Lifesciences Corp. from acquiring medical device maker JenaValve Technology Inc.